After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Immunovant Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Immunovant Inc is $3.44B. A total of 0.83 million shares were traded on the day, compared to an average of 1.15M shares.
In the most recent transaction, Macias William L. sold 2,055 shares of IMVT for 20.86 per share on Feb 19 ’25. After the transaction, the Chief Medical Officer now owns 357,353 company shares. In a previous transaction on Feb 19 ’25, Barnett Eva Renee sold 2,814 shares at 20.86 per share. IMVT shares that Chief Financial Officer owns now total 321,952.
Among the insiders who sold shares, Salzmann Peter disposed of 15,439 shares on Feb 19 ’25 at a per-share price of $20.86. This resulted in the Chief Executive Officer holding 948,786 shares of IMVT after the transaction. In another insider transaction, MARK S LEVINE bought 69,763 shares at $20.16 per share on Feb 14 ’25.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, IMVT has a high of $39.55 and a low of $19.07.
As of this writing, IMVT has an earnings estimate of -$0.72 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.56 per share and a lower estimate of -$0.86.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. IMVT’s latest balance sheet shows that the firm has $493.82M in Cash & Short Term Investments as of fiscal 2022. There were $2.36M in debt and $44.52M in liabilities at the time. Its Book Value Per Share was $2.40, while its Total Shareholder’s Equity was $469.82M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IMVT is Buy with a score of 4.85.
